This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Shire, US.
Reference
Agh T, et al. The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA. Clinical Drug Investigation : 25 Feb 2016. Available from: URL: http://dx.doi.org/10.1007/s40261-016-0381-3
Rights and permissions
About this article
Cite this article
Lisdexamfetamine dimesylate cost effective for binge-eating. PharmacoEcon Outcomes News 748, 33 (2016). https://doi.org/10.1007/s40274-016-2884-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2884-9